Effectiveness and tolerability of nimotuzumab in unresectable, locally advanced/metastatic esophageal cancer: Indian hospital-based retrospective evidence

CONTEXT: Epidermal growth factor receptor (EGFR) is overly expressed in esophageal squamous cell carcinoma (ESCC) and is important prognostic and predictive biomarker. Nimotuzumab is a humanized anti-EGFR monoclonal antibody and has documented promising clinical outcomes and survival rates in variou...

Descripción completa

Detalles Bibliográficos
Autores principales: Subramanian, Sundaram, Sridharan, Nithya, Balasundaram, V., Chaudhari, Sameer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
ORIGINAL ARTICLE: Head and Neck Cancers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6498719/
https://www.ncbi.nlm.nih.gov/pubmed/31069192
http://dx.doi.org/10.4103/sajc.sajc_89_18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6498719/
https://www.ncbi.nlm.nih.gov/pubmed/31069192
http://dx.doi.org/10.4103/sajc.sajc_89_18

Ejemplares similares